HEADER IMMUNE SYSTEM 12-OCT-17 6BAE TITLE TRASTUZUMAB FAB V3 IN COMPLEX WITH CQFDLSTRRLKC COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRASTUZUMAB FAB LIGHT CHAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: IG KAPPA CHAIN C REGION,IG KAPPA CHAIN C REGION AG,IG KAPPA COMPND 5 CHAIN C REGION CUM,IG KAPPA CHAIN C REGION EU,IG KAPPA CHAIN C REGION COMPND 6 OU,IG KAPPA CHAIN C REGION ROY,IG KAPPA CHAIN C REGION TI; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: TRASTUZUMAB FAB HEAVY CHAIN; COMPND 10 CHAIN: B; COMPND 11 ENGINEERED: YES; COMPND 12 MUTATION: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: PROTEIN L; COMPND 15 CHAIN: E; COMPND 16 ENGINEERED: YES; COMPND 17 MUTATION: YES; COMPND 18 MOL_ID: 4; COMPND 19 MOLECULE: IMMUNOGLOBULIN G BINDING PROTEIN A; COMPND 20 CHAIN: C; COMPND 21 ENGINEERED: YES; COMPND 22 MOL_ID: 5; COMPND 23 MOLECULE: MEDITOPE; COMPND 24 CHAIN: D; COMPND 25 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS, HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 10090, 9606; SOURCE 5 GENE: IGKC; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: MUS MUSCULUS, HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 10090, 9606; SOURCE 12 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 14 MOL_ID: 3; SOURCE 15 ORGANISM_SCIENTIFIC: FINEGOLDIA MAGNA; SOURCE 16 ORGANISM_COMMON: PEPTOSTREPTOCOCCUS MAGNUS; SOURCE 17 ORGANISM_TAXID: 1260; SOURCE 18 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 20 MOL_ID: 4; SOURCE 21 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS; SOURCE 22 ORGANISM_TAXID: 1280; SOURCE 23 GENE: SPA; SOURCE 24 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 25 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 26 MOL_ID: 5; SOURCE 27 SYNTHETIC: YES; SOURCE 28 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 29 ORGANISM_TAXID: 32630 KEYWDS MONOCLONAL ANTIBODY, FAB, MEDITOPE, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR K.P.BZYMEK,J.D.KING,J.C.WILLIAMS REVDAT 2 04-OCT-23 6BAE 1 REMARK REVDAT 1 05-SEP-18 6BAE 0 JRNL AUTH J.D.KING,Y.MA,Y.C.KUO,K.P.BZYMEK,L.H.GOODSTEIN,K.MEYER, JRNL AUTH 2 R.E.MOORE,D.CROW,D.M.COLCHER,G.SINGH,D.A.HORNE,J.C.WILLIAMS JRNL TITL TEMPLATE-CATALYZED, DISULFIDE CONJUGATION OF MONOCLONAL JRNL TITL 2 ANTIBODIES USING A NATURAL AMINO ACID TAG. JRNL REF BIOCONJUG. CHEM. V. 29 2074 2018 JRNL REFN ISSN 1520-4812 JRNL PMID 29763554 JRNL DOI 10.1021/ACS.BIOCONJCHEM.8B00284 REMARK 2 REMARK 2 RESOLUTION. 2.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.53 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 37064 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1853 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.5330 - 5.0265 0.98 2860 150 0.1658 0.1947 REMARK 3 2 5.0265 - 3.9918 0.99 2761 145 0.1296 0.1666 REMARK 3 3 3.9918 - 3.4878 1.00 2724 144 0.1429 0.2024 REMARK 3 4 3.4878 - 3.1691 1.00 2721 143 0.1632 0.1768 REMARK 3 5 3.1691 - 2.9421 1.00 2706 142 0.1892 0.2528 REMARK 3 6 2.9421 - 2.7688 1.00 2703 143 0.1906 0.2829 REMARK 3 7 2.7688 - 2.6302 1.00 2695 142 0.1964 0.2810 REMARK 3 8 2.6302 - 2.5157 1.00 2693 141 0.1976 0.2475 REMARK 3 9 2.5157 - 2.4189 1.00 2671 141 0.2089 0.2697 REMARK 3 10 2.4189 - 2.3354 1.00 2700 142 0.2063 0.2792 REMARK 3 11 2.3354 - 2.2624 1.00 2668 140 0.2118 0.3031 REMARK 3 12 2.2624 - 2.1978 1.00 2689 142 0.2125 0.2693 REMARK 3 13 2.1978 - 2.1399 1.00 2620 138 0.2205 0.2699 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.180 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4486 REMARK 3 ANGLE : 0.872 6110 REMARK 3 CHIRALITY : 0.051 681 REMARK 3 PLANARITY : 0.005 795 REMARK 3 DIHEDRAL : 12.558 2716 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6BAE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-OCT-17. REMARK 100 THE DEPOSITION ID IS D_1000230534. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-DEC-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37070 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.140 REMARK 200 RESOLUTION RANGE LOW (A) : 33.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.14 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4IOI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS PH 7.5, 24 MM NACL, 15% PEG REMARK 280 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.65500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.81500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.47000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 58.81500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.65500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.47000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY E 18 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU B 1 CG CD OE1 OE2 REMARK 470 LYS B 221 CG CD CE NZ REMARK 470 LYS E 78 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER D 6 O HOH D 101 1.86 REMARK 500 O HOH B 434 O HOH B 443 1.96 REMARK 500 O HOH B 467 O HOH B 481 1.97 REMARK 500 OD2 ASP A 17 O HOH A 301 1.98 REMARK 500 O HOH C 140 O HOH C 141 2.06 REMARK 500 O HOH B 421 O HOH B 473 2.07 REMARK 500 O HOH A 445 O HOH A 516 2.07 REMARK 500 O HOH B 497 O HOH B 503 2.07 REMARK 500 OD2 ASP A 1 O HOH A 302 2.07 REMARK 500 O HOH B 436 O HOH B 480 2.08 REMARK 500 O HOH A 446 O HOH A 474 2.08 REMARK 500 NE2 GLN B 13 O HOH B 301 2.10 REMARK 500 O HOH B 365 O HOH B 408 2.11 REMARK 500 O HOH B 340 O HOH B 469 2.13 REMARK 500 O HOH B 449 O HOH B 472 2.15 REMARK 500 O HOH A 315 O HOH A 398 2.16 REMARK 500 O HOH A 508 O HOH A 509 2.16 REMARK 500 O HOH B 422 O HOH B 440 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 30 -129.72 58.55 REMARK 500 ALA A 51 -41.63 74.29 REMARK 500 SER A 77 85.16 -156.12 REMARK 500 ASN A 138 60.37 63.50 REMARK 500 ASP A 151 51.82 39.38 REMARK 500 ASN A 152 -0.28 72.88 REMARK 500 TYR B 105 57.63 -92.88 REMARK 500 ASP B 151 66.43 66.02 REMARK 500 SER B 222 -82.38 -77.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH E 140 DISTANCE = 6.94 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6B9Z RELATED DB: PDB REMARK 900 RELATED ID: 6B9Y RELATED DB: PDB DBREF 6BAE A 1 107 PDB 6BAE 6BAE 1 107 DBREF 6BAE A 108 214 UNP P01834 IGKC_HUMAN 1 107 DBREF 6BAE B 1 108 PDB 6BAE 6BAE 1 108 DBREF 6BAE B 109 223 UNP S6B291 S6B291_HUMAN 125 239 DBREF 6BAE E 21 81 UNP Q51918 Q51918_FINMA 477 537 DBREF 6BAE C 4 54 UNP Q2UW42 Q2UW42_STAAU 74 124 DBREF 6BAE D 0 13 PDB 6BAE 6BAE 0 13 SEQADV 6BAE CYS B 175 UNP S6B291 ALA 191 ENGINEERED MUTATION SEQADV 6BAE LYS B 217 UNP S6B291 ARG 233 ENGINEERED MUTATION SEQADV 6BAE GLY E 18 UNP Q51918 EXPRESSION TAG SEQADV 6BAE SER E 19 UNP Q51918 EXPRESSION TAG SEQADV 6BAE GLU E 20 UNP Q51918 EXPRESSION TAG SEQADV 6BAE ILE E 34 UNP Q51918 THR 490 ENGINEERED MUTATION SEQADV 6BAE ALA E 55 UNP Q51918 ASP 511 ENGINEERED MUTATION SEQADV 6BAE ASN E 73 UNP Q51918 TYR 529 ENGINEERED MUTATION SEQADV 6BAE HIS E 74 UNP Q51918 THR 530 ENGINEERED MUTATION SEQADV 6BAE MET E 75 UNP Q51918 ILE 531 ENGINEERED MUTATION SEQADV 6BAE GLY C 1 UNP Q2UW42 EXPRESSION TAG SEQADV 6BAE SER C 2 UNP Q2UW42 EXPRESSION TAG SEQADV 6BAE TYR C 3 UNP Q2UW42 EXPRESSION TAG SEQRES 1 A 214 ASP ILE GLN MET THR GLN SER PRO ILE LEU LEU SER ALA SEQRES 2 A 214 SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG ALA SER SEQRES 3 A 214 GLN ASP VAL ASN THR ALA VAL ALA TRP TYR GLN GLN ARG SEQRES 4 A 214 THR ASN GLY SER PRO ARG LEU LEU ILE TYR SER ALA SER SEQRES 5 A 214 PHE LEU TYR SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 A 214 ARG SER GLY THR ASP PHE THR LEU THR ILE SER SER LEU SEQRES 7 A 214 GLN PRO GLU ASP GLU ALA ASP TYR TYR CYS GLN GLN HIS SEQRES 8 A 214 TYR THR THR PRO PRO THR PHE GLY ALA GLY THR LYS VAL SEQRES 9 A 214 GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE SEQRES 10 A 214 PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SEQRES 11 A 214 SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU SEQRES 12 A 214 ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER SEQRES 13 A 214 GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS SEQRES 14 A 214 ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SER SEQRES 15 A 214 LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU SEQRES 16 A 214 VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER SEQRES 17 A 214 PHE ASN ARG GLY GLU CYS SEQRES 1 B 223 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 B 223 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 B 223 PHE ASN ILE LYS ASP THR TYR ILE HIS TRP VAL ARG GLN SEQRES 4 B 223 SER PRO GLY LYS GLY LEU GLU TRP VAL ALA ARG ILE TYR SEQRES 5 B 223 PRO THR ASN GLY TYR THR ARG TYR ALA ASP SER VAL LYS SEQRES 6 B 223 GLY ARG PHE THR ILE SER ALA ASP THR SER LYS ASN THR SEQRES 7 B 223 ALA TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR SEQRES 8 B 223 ALA ILE TYR TYR CYS SER ARG TRP GLY GLY ASP GLY PHE SEQRES 9 B 223 TYR ALA MET ASP TYR TRP GLY GLN GLY THR LEU VAL THR SEQRES 10 B 223 VAL SER SER ALA SER THR LYS GLY PRO SER VAL PHE PRO SEQRES 11 B 223 LEU ALA PRO SER SER LYS SER THR SER GLY GLY THR ALA SEQRES 12 B 223 ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO SEQRES 13 B 223 VAL THR VAL SER TRP ASN SER GLY ALA LEU THR SER GLY SEQRES 14 B 223 VAL HIS THR PHE PRO CYS VAL LEU GLN SER SER GLY LEU SEQRES 15 B 223 TYR SER LEU SER SER VAL VAL THR VAL PRO SER SER SER SEQRES 16 B 223 LEU GLY THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS SEQRES 17 B 223 PRO SER ASN THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SEQRES 18 B 223 SER CYS SEQRES 1 E 64 GLY SER GLU VAL THR ILE LYS VAL ASN LEU ILE PHE ALA SEQRES 2 E 64 ASP GLY LYS ILE GLN THR ALA GLU PHE LYS GLY THR PHE SEQRES 3 E 64 GLU GLU ALA THR ALA GLU ALA TYR ARG TYR ALA ALA LEU SEQRES 4 E 64 LEU ALA LYS VAL ASN GLY GLU TYR THR ALA ASP LEU GLU SEQRES 5 E 64 ASP GLY GLY ASN HIS MET ASN ILE LYS PHE ALA GLY SEQRES 1 C 54 GLY SER TYR ASN LYS ASP GLN GLN SER ALA PHE TYR GLU SEQRES 2 C 54 ILE LEU ASN MET PRO ASN LEU ASN GLU ALA GLN ARG ASN SEQRES 3 C 54 GLY PHE ILE GLN SER LEU LYS ASP ASP PRO SER GLN SER SEQRES 4 C 54 THR ASN VAL LEU GLY GLU ALA LYS LYS LEU ASN GLU SER SEQRES 5 C 54 GLN ALA SEQRES 1 D 14 ACE CYS GLN PHE ASP LEU SER THR ARG ARG LEU LYS CYS SEQRES 2 D 14 NH2 HET ACE D 0 3 HET NH2 D 13 1 HETNAM ACE ACETYL GROUP HETNAM NH2 AMINO GROUP FORMUL 5 ACE C2 H4 O FORMUL 5 NH2 H2 N FORMUL 6 HOH *535(H2 O) HELIX 1 AA1 GLN A 79 GLU A 83 5 5 HELIX 2 AA2 SER A 121 LYS A 126 1 6 HELIX 3 AA3 LYS A 183 GLU A 187 1 5 HELIX 4 AA4 ASN B 28 THR B 32 5 5 HELIX 5 AA5 THR B 74 LYS B 76 5 3 HELIX 6 AA6 ARG B 87 THR B 91 5 5 HELIX 7 AA7 GLY B 101 PHE B 104 5 4 HELIX 8 AA8 SER B 134 LYS B 136 5 3 HELIX 9 AA9 SER B 163 ALA B 165 5 3 HELIX 10 AB1 SER B 194 LEU B 196 5 3 HELIX 11 AB2 LYS B 208 ASN B 211 5 4 HELIX 12 AB3 THR E 42 GLY E 62 1 21 HELIX 13 AB4 GLU E 69 GLY E 72 5 4 HELIX 14 AB5 ASN C 4 MET C 17 1 14 HELIX 15 AB6 ASN C 21 ASP C 35 1 15 HELIX 16 AB7 GLN C 38 GLN C 53 1 16 SHEET 1 AA1 4 MET A 4 SER A 7 0 SHEET 2 AA1 4 VAL A 19 ALA A 25 -1 O THR A 22 N SER A 7 SHEET 3 AA1 4 ASP A 70 ILE A 75 -1 O PHE A 71 N CYS A 23 SHEET 4 AA1 4 PHE A 62 SER A 67 -1 N SER A 63 O THR A 74 SHEET 1 AA2 5 PHE A 53 LEU A 54 0 SHEET 2 AA2 5 ARG A 45 TYR A 49 -1 N TYR A 49 O PHE A 53 SHEET 3 AA2 5 VAL A 33 GLN A 38 -1 N TRP A 35 O LEU A 47 SHEET 4 AA2 5 ALA A 84 GLN A 90 -1 O TYR A 87 N TYR A 36 SHEET 5 AA2 5 THR A 97 PHE A 98 -1 O THR A 97 N GLN A 90 SHEET 1 AA310 PHE A 53 LEU A 54 0 SHEET 2 AA310 ARG A 45 TYR A 49 -1 N TYR A 49 O PHE A 53 SHEET 3 AA310 VAL A 33 GLN A 38 -1 N TRP A 35 O LEU A 47 SHEET 4 AA310 ALA A 84 GLN A 90 -1 O TYR A 87 N TYR A 36 SHEET 5 AA310 THR A 102 LYS A 107 -1 O VAL A 104 N ALA A 84 SHEET 6 AA310 LEU A 10 SER A 14 1 N LEU A 11 O LYS A 103 SHEET 7 AA310 ILE E 34 GLY E 41 -1 O THR E 36 N SER A 12 SHEET 8 AA310 VAL E 21 ILE E 28 -1 N VAL E 21 O GLY E 41 SHEET 9 AA310 HIS E 74 PHE E 79 1 O ILE E 77 N ASN E 26 SHEET 10 AA310 TYR E 64 ASP E 67 -1 N ASP E 67 O ASN E 76 SHEET 1 AA4 4 SER A 114 PHE A 118 0 SHEET 2 AA4 4 THR A 129 PHE A 139 -1 O LEU A 135 N PHE A 116 SHEET 3 AA4 4 TYR A 173 SER A 182 -1 O LEU A 179 N VAL A 132 SHEET 4 AA4 4 SER A 159 VAL A 163 -1 N SER A 162 O SER A 176 SHEET 1 AA5 4 ALA A 153 LEU A 154 0 SHEET 2 AA5 4 LYS A 145 VAL A 150 -1 N VAL A 150 O ALA A 153 SHEET 3 AA5 4 VAL A 191 THR A 197 -1 O GLU A 195 N GLN A 147 SHEET 4 AA5 4 VAL A 205 ASN A 210 -1 O LYS A 207 N CYS A 194 SHEET 1 AA6 4 GLN B 3 SER B 7 0 SHEET 2 AA6 4 LEU B 18 SER B 25 -1 O SER B 25 N GLN B 3 SHEET 3 AA6 4 THR B 78 MET B 83 -1 O MET B 83 N LEU B 18 SHEET 4 AA6 4 PHE B 68 ASP B 73 -1 N ASP B 73 O THR B 78 SHEET 1 AA7 6 LEU B 11 VAL B 12 0 SHEET 2 AA7 6 THR B 114 VAL B 118 1 O THR B 117 N VAL B 12 SHEET 3 AA7 6 ALA B 92 TRP B 99 -1 N TYR B 94 O THR B 114 SHEET 4 AA7 6 TYR B 33 SER B 40 -1 N VAL B 37 O TYR B 95 SHEET 5 AA7 6 GLY B 44 ILE B 51 -1 O GLU B 46 N ARG B 38 SHEET 6 AA7 6 THR B 58 TYR B 60 -1 O ARG B 59 N ARG B 50 SHEET 1 AA8 4 LEU B 11 VAL B 12 0 SHEET 2 AA8 4 THR B 114 VAL B 118 1 O THR B 117 N VAL B 12 SHEET 3 AA8 4 ALA B 92 TRP B 99 -1 N TYR B 94 O THR B 114 SHEET 4 AA8 4 MET B 107 TRP B 110 -1 O TYR B 109 N ARG B 98 SHEET 1 AA9 4 SER B 127 LEU B 131 0 SHEET 2 AA9 4 THR B 142 TYR B 152 -1 O LEU B 148 N PHE B 129 SHEET 3 AA9 4 TYR B 183 PRO B 192 -1 O LEU B 185 N VAL B 149 SHEET 4 AA9 4 VAL B 170 THR B 172 -1 N HIS B 171 O VAL B 188 SHEET 1 AB1 4 THR B 138 SER B 139 0 SHEET 2 AB1 4 THR B 142 TYR B 152 -1 O THR B 142 N SER B 139 SHEET 3 AB1 4 TYR B 183 PRO B 192 -1 O LEU B 185 N VAL B 149 SHEET 4 AB1 4 VAL B 176 LEU B 177 -1 N VAL B 176 O SER B 184 SHEET 1 AB2 3 THR B 158 TRP B 161 0 SHEET 2 AB2 3 ILE B 202 HIS B 207 -1 O ASN B 204 N SER B 160 SHEET 3 AB2 3 THR B 212 LYS B 217 -1 O VAL B 214 N VAL B 205 SHEET 1 AB3 2 GLN D 2 ASP D 4 0 SHEET 2 AB3 2 ARG D 9 LYS D 11 -1 O LYS D 11 N GLN D 2 SSBOND 1 CYS A 23 CYS A 88 1555 1555 2.06 SSBOND 2 CYS A 134 CYS A 194 1555 1555 2.02 SSBOND 3 CYS A 214 CYS B 223 1555 1555 2.03 SSBOND 4 CYS B 22 CYS B 96 1555 1555 2.03 SSBOND 5 CYS B 147 CYS B 203 1555 1555 2.05 SSBOND 6 CYS D 1 CYS D 12 1555 1555 2.03 LINK C ACE D 0 N CYS D 1 1555 1555 1.32 LINK C CYS D 12 N NH2 D 13 1555 1555 1.33 CISPEP 1 SER A 7 PRO A 8 0 -11.65 CISPEP 2 THR A 94 PRO A 95 0 2.85 CISPEP 3 TYR A 140 PRO A 141 0 2.96 CISPEP 4 PHE B 153 PRO B 154 0 -8.59 CISPEP 5 GLU B 155 PRO B 156 0 1.74 CISPEP 6 GLU B 155 PRO B 156 0 1.18 CRYST1 53.310 104.940 117.630 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018758 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009529 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008501 0.00000